![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 2
Zeitschriftenartikel
Rini, Brian I.; Powles, Thomas; Atkins, Michael B.; Escudier, Bernard; McDermott, David F.; Suarez, Cristina; Bracarda, Sergio; Stadler, Walter M.; Donskov, Frede; Lee, Jae Lyun; Hawkins, Robert; Ravaud, Alain; Alekseev, Boris; Staehler, Michael; Uemura, Motohide; De Giorgi, Ugo; Mellado, Begona; Porta, Camillo; Melichar, Bohuslav; Gurney, Howard; Bedke, Jens; Choueiri, Toni K.; Parnis, Francis; Khaznadar, Tarik; Thobhani, Alpa; Li, Shi; Piault-Louis, Elisabeth; Frantz, Gretchen; Huseni, Mahrukh; Schiff, Christina; Green, Marjorie C. und Motzer, Robert J.
(2019):
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.
In: Lancet, Bd. 393, Nr. 10189: S. 2404-2415
Msaouel, Pavlos; Hong, Andrew L.; Mullen, Elizabeth A.; Atkins, Michael B.; Walker, Cheryl Lyn; Lee, Chung-Han; Carden, Marcus A.; Genovese, Giannicola; Linehan, W. Marston; Rao, Priya; Merino, Maria J.; Grodman, Howard; Dome, Jeffrey S.; Fernandez, Conrad; Geller, James; Apolo, Andrea B.; Daw, Najat C.; Hodges, H. Courtney; Moxey-Mims, Marva; Wei, Darmood; Bottaro, Donald P.; Staehler, Michael; Karam, Jose A.; Rathmell, W. Kimryn und Tannir, Nizar M.
(2019):
Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma.
In: Clinical Genitourinary Cancer, Bd. 17, Nr. 1: S. 1-6